Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

CUSIP: 690469101

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
146,457,154
Total 13F shares
17,761,607
Share change
+9,206,576
Total reported value
$73,712,290
Price per share
$4.15
Number of holders
58
Value change
+$38,255,959
Number of buys
47
Number of sells
9

Security key

690469101

Report period

Q4 2019

Institutions

58

Top holders

10

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BVF INC/IL
13F
Company
1.6%
2,321,236
$7,521,000 30 Sep 2019
13F
VANGUARD GROUP INC
13F
Company
0.73%
1,064,568
$3,449,000 30 Sep 2019
13F
CHI Advisors LLC
13F
Company
0.5%
727,260
$2,356,000 30 Sep 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.4%
586,725
$1,901,000 30 Sep 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.29%
421,700
$1,366,000 30 Sep 2019
13F
Tekla Capital Management LLC
13F
Company
0.25%
372,733
$1,208,000 30 Sep 2019
13F
Granite Point Capital Management, L.P.
13F
Company
0.24%
348,263
$1,128,000 30 Sep 2019
13F
AWH Capital, L.P.
13F
Company
0.18%
260,000
$842,000 30 Sep 2019
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.16%
232,738
$755,000 30 Sep 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
227,042
$735,000 30 Sep 2019
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
210,200
$681,000 30 Sep 2019
13F
Informed Momentum Co LLC
13F
Company
0.14%
206,118
$668,000 30 Sep 2019
13F
BlackRock Finance, Inc.
13F
Company
0.09%
134,798
$437,000 30 Sep 2019
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.09%
129,600
$420,000 30 Sep 2019
13F
Redmile Group, LLC
13F
Company
0.08%
121,950
$395,000 30 Sep 2019
13F
Fairpointe Capital LLC
13F
Company
0.07%
101,000
$327,000 30 Sep 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.07%
100,961
$327,000 30 Sep 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.07%
97,393
$316,000 30 Sep 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
90,701
$294,000 30 Sep 2019
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.05%
79,395
$257,000 30 Sep 2019
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.05%
77,716
$252,000 30 Sep 2019
13F
MORGAN STANLEY
13F
Company
0.04%
59,243
$192,000 30 Sep 2019
13F
NORTHERN TRUST CORP
13F
Company
0.04%
58,716
$190,000 30 Sep 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
35,932
$116,000 30 Sep 2019
13F
Virtu Financial LLC
13F
Company
0.02%
24,646
$80,000 30 Sep 2019
13F
MARSHALL WACE, LLP
13F
Company
0.01%
18,060
$59,000 30 Sep 2019
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.01%
18,000
$58,000 30 Sep 2019
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.01%
17,400
$56,000 30 Sep 2019
13F
Creative Planning
13F
Company
0.01%
14,932
$48,000 30 Sep 2019
13F
Marshall Wace North America L.P.
13F
Company
0.01%
12,735
$41,000 30 Sep 2019
13F
WINTON GROUP Ltd
13F
Company
0.01%
10,388
$34,000 30 Sep 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
10,269
$33,000 30 Sep 2019
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0%
4,694
$15,000 30 Sep 2019
13F
ROYAL BANK OF CANADA
13F
Company
0%
3,356
$11,000 30 Sep 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
3,007
$10,000 30 Sep 2019
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1,551
$5,025 30 Sep 2019
13F
CITIGROUP INC
13F
Company
0%
1,486
$5,000 30 Sep 2019
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
200
$1,000 30 Sep 2019
13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2019

As of 31 Dec 2019, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,761,607 shares. The largest 10 holders included Consonance Capital Management LP, FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, AXA, CHI Advisors LLC, BVF INC/IL, CITIGROUP INC, WELLS FARGO & COMPANY/MN, and BlackRock Inc.. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
37
Q4 2019 holders
58
Holder diff
21
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 Value $ Q4 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .